Literature DB >> 6339309

Studies on the mechanism of liver injury by macrophage-mediated cytotoxicity--partial purification of cytotoxic factor detected in the culture supernatant of activated macrophages.

Y Mizoguchi, H Tsutsui, T Monna, S Yamamoto, S Morisawa.   

Abstract

The culture supernatant of activated lymphocytes was shown to contain macrophage activating factor (MAF), a kind of lymphokine, which activated the peritoneal macrophages prepared from guinea pigs. When the culture fluid of the MAF-activated macrophages was added to the isolated liver cells, a significant inhibition of their albumin biosynthesis was demonstrated. The active material was recovered in a definitive fraction by gel filtration using a Sephadex G-75 column and this was further fractionated into two fractions by DEAE-cellulose column chromatography, suggesting that at least two kinds of active substances existed. By isoelectric focusing electrophoresis it was shown that these two active principles were substances having different isoelectric points, by isoelectric focusing electrophoresis. These results suggest that some cytotoxic or cytostatic materials are produced from the lymphokine-activated macrophages and they may participate in the occurrence of liver injury at least partially.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6339309     DOI: 10.1007/bf02774858

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  10 in total

1.  An improved method for the isolation of hepatocytes from liver slices. Selective removal of Trypan blue-dyeable cells.

Authors:  P Bellemann; R Gebhardt; D Mecke
Journal:  Anal Biochem       Date:  1977-08       Impact factor: 3.365

Review 2.  The macrophage as a secretory cell.

Authors:  R C Page; P Davies; A C Allison
Journal:  Int Rev Cytol       Date:  1978

3.  Experimental chronic active hepatitis in rabbits following immunization with human liver proteins.

Authors:  K H Büschenfelde; F K Kössling; P A Miescher
Journal:  Clin Exp Immunol       Date:  1972-05       Impact factor: 4.330

4.  Studies on the pathogenesis of experimental chronic active hepatitis in rabbits. I. Induction of the disease and protective effect of allogeneic liver specific proteins.

Authors:  K H Meyer zum Büschenfelde; U Hopf
Journal:  Br J Exp Pathol       Date:  1974-10

5.  Liver-specific antigens of different species. II. Localization of a membrane antigen at cell surface of isolated hepatocytes.

Authors:  U Hopf; K H Meyer zum Büschenfelde; J Freudenberg
Journal:  Clin Exp Immunol       Date:  1974-01       Impact factor: 4.330

6.  Liver specific antigens. Purification and characterization.

Authors:  P A Miescher
Journal:  Clin Exp Immunol       Date:  1972-01       Impact factor: 4.330

7.  Possible involvement of macrophage-mediated hepatocytotoxicity in chronic active hepatitis: the induction of liver cell injury by culture supernatant of MAF-activated macrophages.

Authors:  Y Mizoguchi; T Shiba; F Ohnishi; T Monna; S Yamamoto; K Nakai; S Otani; S Morisawa
Journal:  Hepatogastroenterology       Date:  1981-10

8.  Immunological studies on chronic active hepatitis: possible involvement of macrophage-mediated cytotoxicity in its immunopathogenesis.

Authors:  Y Mizoguchi; T Shiba; F Ohnishi; T Monna; S Yamamoto; S Morisawa
Journal:  Hepatogastroenterology       Date:  1981-10

9.  Cell-mediated immunity to a human liver-specific antigen in patients with active chronic hepatitis and primary biliary cirrhosis.

Authors:  J Miller; M G Smith; C G Mitchell; W D Reed; A L Eddleston; R Williams
Journal:  Lancet       Date:  1972-08-12       Impact factor: 79.321

10.  Role of mononuclear infiltrating cells in pathogenesis of hepatitis.

Authors:  J Ferluga; A C Allison
Journal:  Lancet       Date:  1978-09-16       Impact factor: 79.321

  10 in total
  1 in total

1.  Generation of reactive oxygen species by Kupffer cells and blood monocytes during intestinal amebiasis in guinea pigs.

Authors:  K J Virk; N K Ganguly; R C Mahajan; S R Bhushnurmath; J B Dilawari
Journal:  Gastroenterol Jpn       Date:  1988-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.